The National Institute of Allergy and Infectious Diseases (NIAID) conducts and supports research to understand, treat, and prevent infectious and allergic diseases.

For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world. NIAID is one of the 27 Institutes and Centers of the National Institutes of Health (NIH). NIAID Research Areas HIV/AIDS

Dr. Marrazzo began her tenure as the sixth NIAID Director in the fall of 2023. She oversees a $6.3 billion budget that supports research to advance the understanding, diagnosis, treatment and prevention of infectious, immunologic, and allergic diseases.

Apr 16, 2021 · NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States ...

Oct 3, 2024 · Dr. Marrazzo began her tenure as the sixth NIAID Director in the fall of 2023. She oversees a $6.6 billion budget that supports research to advance the understanding, diagnosis, treatment and prevention of infectious, immunologic, and allergic diseases.

Mar 21, 2025 · Dr. Fauci served as NIAID Director from 1984 to 2022. He oversaw an extensive research portfolio of basic and applied research to prevent, diagnose, and treat established infectious diseases such as HIV/AIDS, respiratory infections, diarrheal diseases, tuberculosis, and malaria as well as emerging diseases such as Ebola, Zika, and COVID-19.

Aug 17, 2023 · Menu Block - About NIAID. Organization Menu. Organization. Office of the Director. Director, Jeanne Marrazzo, M.D., M.P.H. Senior Leadership. Office of the Chief of Staff for the Immediate Office of the Director (IOD) Office of Science Management and Operations (OSMO) OSMO Organizational Chart.

Dec 18, 2024 · Submitting complete and timely Federal Financial Reports is an important step to ensure NIAID’s prompt review and consideration of any carryover requests.

Mar 16, 2020 · Prior to the COVID-19 outbreak, NIAID and Moderna scientists had been working together on an investigational vaccine to protect against Middle East respiratory syndrome (MERS), another type of coronavirus.

Dec 4, 2024 · Email us at [email protected] for help navigating NIAID’s grant and contract policies and procedures.